Jula Inrig, CHIEF MEDICAL OFFICER at Travere Therapeutics, Inc. (TVTX), sold 1,779 shares at $32.85 ($57K) on 2026-02-04, disclosed to the SEC on 2026-02-05.
Scheduled sale ($57k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.11 | 1,547 | $50K | 86.7% |
| 2 | $32.85 | 232 | $8K | 13.3% |
| Total | $32.21 avg | 1,779 | $57K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $346K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $223K | — | Filing → |
| TVTX | SELL | 2026-01-07 | $98K | — | Filing → |